single arm:Camrelizumab combined with Apatinib

3 trials

Sponsors

Nanjing Gulou Hospital, Inner Mongolia Autonomous Region Cancer Hospital, The Affiliated Hospital of Nanjing University Medical School

Conditions

Extensive-Stage Small Cell Lung CancerLiver cancerSolid malignant tumor

Early Phase 1

Clinical study for camrelizumab combined with apatinib neoadjuvant in the treatment of resectable advanced hepatocellular carcinoma

Active, not recruitingChiCTR1900026022

Nanjing Gulou HospitalLiver cancer

Start: 2019-10-01Updated: 2019-09-30

Phase 4

Clinical study for combination of Camrelizumab and Apatinib in the treatment of advanced solid tumor

Active, not recruitingChiCTR1900027697

Inner Mongolia Autonomous Region Cancer HospitalSolid malignant tumor

Start: 2019-12-16Updated: 2019-11-25

An Observational Study of Camrelizumab Combined With Apatinib for Extensive-Stage Small Cell Lung Cancer After Different Effects of Etoposide / Carboplatin Therapy

RecruitingChiCTR1900028023

The Affiliated Hospital of Nanjing University Medical SchoolExtensive-Stage Small Cell Lung Cancer

Start: 2020-02-01Updated: 2020-04-27